David Beno, Ph.D.

David Beno, Ph.D. has a diverse work experience spanning several companies in the field of biosciences and medical research.

David is currently the Chief Executive Officer and Chief Scientific Officer at Xeno Biosciences, a position they have held since January 2021. David also serves as a Board Member for the company since March 2016.

In addition, David Beno has served as an Advisory Board Member for Panaceutics and the Future Food Tech Summit from September 2017 to July 2020.

Prior to their roles at Xeno Biosciences and in advisory boards, they worked at Abbott from 2002 to 2017. At Abbott, they held positions such as Senior Investigator and was personally responsible for PK/PD and facilitated project coordinating for multifunctional teams in diverse therapeutic areas. David brought 12 drugs to market and authored regulatory filings. David also reviewed licensing opportunities and oversaw interactions with external biotech and academic labs.

Before joining Abbott, they worked at Rush University Medical Center as an Assistant Professor from 1996 to 2002 and at the University of Chicago Medicine as a Research Associate from 1990 to 2002.

Overall, David Beno, Ph.D. has extensive experience in leadership roles, scientific research, project coordination, regulatory affairs, and academic teaching.

David Beno, Ph.D., obtained their Bachelor of Science (B.S.) degree in Biology and Chemistry from Illinois College between 1980 and 1984. Subsequently, they attended Loyola University Chicago Stritch School of Medicine from 1984 to 1990, where they earned both their Masters (M.S.) and Doctor of Philosophy (Ph.D.) degrees in Microbiology and Immunology.